Dissolvable Fabric Loaded With Medicine Might Offer Faster Protection Against HIV
July 30th 2014Soon, protection from HIV infection could be as simple as inserting a medicated, disappearing fabric minutes before having sex. University of Washington bioengineers have discovered a potentially faster way to deliver a topical drug that protects women from contracting HIV. Their method spins the drug into silk-like fibers that quickly dissolve when in contact with moisture, releasing higher doses of the drug than possible with other topical materials such as gels or creams.
New Hopkins Curriculum Begins Recruiting an Army of Caregivers as Nurses Take the Lead
July 30th 2014The 31-year-old Moore Clinic operated by the Johns Hopkins AIDS Service at the School of Medicine is a historic operation - the second-oldest AIDS clinic in the country. But when Jason Farley, PhD, MPH, CRNP, looks nowadays at the makeup of Moore’s caregiving staff, he worries that he’s seeing too much history.
The Challenges and Rewards of Fighting the Ebola Outbreak
July 29th 2014“It was great that Mauricio and I arrived the same day; we were able to share first, very shocking, impressions and to go through the process of adapting to difficult working conditions together,” says Dr. Catherine Houlihan, an infectious disease doctor from the United Kingdom deployed through the World Health Organization (WHO) to help respond to the Ebola outbreak in Sierra Leone.
Herpes Remains Active Even When No Symptoms Appear
July 29th 2014Scientists at Australian National University investigating the herpes virus have been surprised to find an ongoing conflict in the cells of sufferers, even when the virus is apparently dormant Herpes Simplex Type 1 is a virus that causes cold sores. It remains in the body’s nervous system indefinitely after infection. Around 80 percent of Australians carry the virus, although it is usually in a dormant state.
Study Reveals How a Potential HIV Drug Exacts a Toll on Viral Populations
July 28th 2014Fifteen years ago, MIT professor John Essigmann and colleagues from the University of Washington had a novel idea for an HIV drug. They thought if they could induce the virus to mutate uncontrollably, they could force it to weaken and eventually die out - a strategy that our immune system uses against many viruses.